Pulsenmore Ltd. Ordinary Shares (PLSM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Pulsenmore Ltd. Ordinary Shares (PLSM) has a cash flow conversion efficiency ratio of -0.304x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-17.10 Million) by net assets ($56.31 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Pulsenmore Ltd. Ordinary Shares for the company's overall valuation and market capitalisation.
Pulsenmore Ltd. Ordinary Shares - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Pulsenmore Ltd. Ordinary Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Pulsenmore Ltd. Ordinary Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Pulsenmore Ltd. Ordinary Shares ranked by their cash flow conversion efficiency. See how well can Pulsenmore Ltd. Ordinary Shares service its debt to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Immo Mcc NV
BR:MCC
|
N/A |
|
Western Gold Resources Ltd
AU:WGR
|
-0.890x |
|
Mobix Labs Inc
NASDAQ:MOBX
|
-0.913x |
|
DOTZ Nano Ltd
AU:DTZ
|
0.228x |
|
Hoth Therapeutics Inc
NASDAQ:HOTH
|
-0.362x |
|
HPMT Holdings Bhd
KLSE:5291
|
-0.045x |
|
OXE Marine AB
ST:OXE
|
-0.326x |
|
Greenbriar Capital Corp
V:GRB
|
-0.048x |
Annual Cash Flow Conversion Efficiency for Pulsenmore Ltd. Ordinary Shares (2019–2025)
The table below shows the annual cash flow conversion efficiency of Pulsenmore Ltd. Ordinary Shares from 2019 to 2025. View PLSM stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $83.09 Million | $-32.88 Million | -0.396x | -21.06% |
| 2024-12-31 | $103.15 Million | $-33.71 Million | -0.327x | -0.64% |
| 2023-12-31 | $130.70 Million | $-42.45 Million | -0.325x | -142.08% |
| 2022-12-31 | $182.67 Million | $-24.51 Million | -0.134x | +17.85% |
| 2021-12-31 | $159.28 Million | $-26.01 Million | -0.163x | +90.90% |
| 2020-12-31 | $5.28 Million | $-9.47 Million | -1.794x | -85.34% |
| 2019-12-31 | $3.95 Million | $-3.83 Million | -0.968x | -- |
About Pulsenmore Ltd. Ordinary Shares
Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products. The company was incorporated in 2014 and is based in Omer, Israel.